Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration

Molecular Psychiatry

Volumn 15, Issue 2, 2010, Pages 185-203

  Tannu, N S ^a   Howell, L L ^b,c   Hemby, S E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Monkey; Nucleus accumbens; Phosphorylation; Protein expression

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADENYLATE KINASE; ADENYLATE KINASE ISOENZYME 5; BETA ACTIN; COCAINE; ENOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE TRANSFERASE; GUANINE DEAMINASE; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; MITOCHONDRIAL PROTEIN; N ETHYLMALEIMIDE SENSITIVE FACTOR; PEROXIREDOXIN 2; PHOSPHOPROTEIN; PROTEIN KINASE C; RAB PROTEIN; SYNTAXIN; SYNTAXIN BINDING PROTEIN 3; TRYPSIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN TISSUE; CELL FUNCTION; CELL METABOLISM; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSOLIC FRACTION; DRUG SELF ADMINISTRATION; INTERVENTION STUDY; INTROSPECTION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RHESUS MONKEY; STAINING; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SEQUENCE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; DATABASES, PROTEIN; DOPAMINE UPTAKE INHIBITORS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; MACACA MULATTA; MALE; NUCLEUS ACCUMBENS; PHOSPHOPROTEINS; PROTEOMICS; SELF ADMINISTRATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 75549083403     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2008.53     Document Type: Article

References (84)

1. SAMHSA. Results from the 2006 National Survey on Drug Use and Health: National Findings. Substance Abuse and Mental Health Services Administration: Rockville, MD, 2007.
2. WHO. Neuroscience of Psychoactive Substance Use and Dependence. World Health Organization: Geneva, 2004.
3. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001; 24: 97-129.
4. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Neurosci Rev 2001; 2: 119-128.
5. Miserendino MJ, Nestler EJ. Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res 1995; 674: 299-306.
6. Self DW, Genova LM, Hope BT, Barnhart WJ, Spencer JJ, Nestler EJ. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci 1998; 18: 1848-1859.
7. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon Jr WA. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accum-bens. J Neurosci 2001; 21: 7397-7403.
8. Carlezon Jr WA, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N et al. Regulation of cocaine reward by CREB. Science 1998; 282: 2272-2275.
9. Hope B, Kosofsky B, Hyman SE, Nestler EJ. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci USA 1992; 89: 5764-5768.
10. Hiroi N, Brown JR, Haile CN, Ye H, Greenberg ME, Nestler EJ. FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci USA 1997; 94: 10397-10402.
11. Haile CN, Hiroi N, Nestler EJ, Kosten TA. Differential behavioral responses to cocaine are associated with dynamics of mesolimbic dopamine proteins in Lewis and Fischer 344 rats. Synapse 2001; 41: 179-190.
12. White FJ, Hu XT, Zhang XF, Wolf ME. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther 1995; 273: 445-454.
13. Hemby SE, Horman B, Tang W. Differential regulation of ionotropic glutamate receptor subunits following cocaine self-administration. Brain Res 2005; 1064: 75-82.
14. Tang W, Wesley M, Freeman WM, Liang B, Hemby SE. Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats. J Neurochem 2004; 89: 1021-1033.
15. Albertson DN, Pruetz B, Schmidt CJ, Kuhn DM, Kapatos G, Bannon MJ. Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. J Neurochem 2004; 88: 1211-1219.
16. Tang WX, Fasulo WH, Mash DC, Hemby SE. Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J Neurochem 2003; 85: 911-924.
17. Hemby SE. Morphine-induced alterations in gene expression of calbindin immunopositive neurons in nucleus accumbens shell and core. Neuroscience 2004; 126: 689-703.
18. Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E et al. Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J Neurochem 2001; 79: 221-224.
19. Yuferov V, Nielsen D, Butelman E, Kreek MJ. Microarray studies of psychostimulant-induced changes in gene expression. Addict Biol 2005; 10: 101-118.
20. Ahmed SH, Lutjens R, van der Stap LD, Lekic D, Romano-Spica V, Morales M et al. Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction. Proc Natl Acad Sci USA 2005; 102: 11533-11538.
21. Backes E, Hemby SE. Discrete cell gene profiling of ventral tegmental dopamine neurons after acute and chronic cocaine self-administration. J Pharmacol Exp Ther 2003; 307: 450-459.
22. Hemby SE. Assessment of genome and proteome profiles in cocaine abuse. Prog Brain Res 2006; 158: 173-195.
23. Tannu N, Mash DC, Hemby SE. Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry 2007; 12: 55-73.
24. Hemby SE, Tang W, Muly EC, Kuhar MJ, Howell L, Mash DC. Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates. J Neurochem 2005; 95: 1785-1793.
25. Zolnierowicz S, Bollen M. Protein phosphorylation and protein phosphatases. De Panne, Belgium, September 19-24, 1999. EMBO J 2000; 19: 483-488.
26. Yamamoto KK, Gonzalez GA, Biggs III WH, Montminy MR. Phosphorylation- induced binding and transcriptional efficacy of nuclear factor CREB. Nature 1988; 334: 494-498.
27. Gonzalez GA, Yamamoto KK, Fischer WH, Karr D, Menzel P, Biggs III W et al. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature 1989; 337: 749-752.
28. Creely H, Khaitovich P. Human brain evolution. In: Hemby SE, Bahn S (eds). Progress in Brain Research: Functional Genomics and Proteomics in the Clinical Neurosciences. Elsevier: Amsterdam, 2006, pp 295-309.
29. Matsumoto I, Alexander-Kaufman K, Iwazaki T, Kashem MA, Matsuda-Matsumoto H. CNS proteomes in alcohol and drug abuse and dependence. Expert Rev Proteomics 2007; 4: 539-552.
30. Howell LL, Wilcox KM. Intravenous drug self-administration in nonhuman primates. In: JJ B (ed). Methods of Behavior Analysis in Neuroscience. CRC Press: Boca Raton, FL, 2001, pp 91-110.
31. Byrd LD. The behavioral effects of cocaine: rate dependency or rate constancy. Eur J Pharmacol 1979; 56: 355-362.
32. Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI et al. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging. J Pharmacol Exp Ther 2004; 309: 959-969.
33. Paxinos G, Huang X-F, Toga A. The Rhesus Monkey Brain in Stereotaxic Coordinates, 1st edn. Academic Press: San Diego, CA, 1999.
34. Tang W-X, Fasulo WH, Mash DC, Hemby SE. Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J Neurochem 2003; 85: 911-924.
35. Churchward MA, Butt RH, Lang JC, Hsu KK, Coorssen JR. Enhanced detergent extraction for analysis of membrane pro-teomes by two-dimensional gel electrophoresis. Proteome Sci 2005; 3: 5.
36. Tannu NS, Hemby SE. Methods for proteomics in neuroscience. In: Hemby SE, Bahn S (eds). Progress in Brain Research: Functional Genomics and Proteomics in the Clinical Neuros-ciences. Elsevier: Amsterdam, 2006, pp 41-82.
37. Tannu N, Hemby SE. Two dimensional fluorescence difference gel electrophoresis (2D-DIGE) for comparative proteomics profiling. Nat Protoc 2006; 1: 1732-1742.
38. Henzel WJ, Billeci TM, Stults JT, Wong SC, Grimley C, Watanabe C. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci USA 1993; 90: 5011-5015.
39. Mann M, Wilm M. Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal Chem 1994; 66: 4390-4399.
40. Yates III JR. Database searching using mass spectrometry data. Electrophoresis 1998; 19: 893-900.
41. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectro-metry. Nat Methods 2007; 4: 207-214.
42. Tannu NS, Hemby SE. De novo protein sequence analysis of Macaca mulatta. BMC Genomics 2007; 8: 270.
43. Martin K, Steinberg TH, Cooley LA, Gee KR, Beechem JM, Patton WF. Quantitative analysis of protein phosphorylation status and protein kinase activity on microarrays using a novel fluorescent phosphorylation sensor dye. Proteomics 2003; 3: 1244-1255. (Pubitemid 36929546)
44. Steinberg TH, Agnew BJ, Gee KR, Leung WY, Goodman T, Schulenberg B et al. Global quantitative phosphoprotein analysis using multiplexed proteomics technology. Proteomics 2003; 3: 1128-1144.
45. Schulenberg B, Goodman TN, Aggeler R, Capaldi RA, Patton WF. Characterization of dynamic and steady-state protein phosphory-lation using a fluorescent phosphoprotein gel stain and mass spectrometry. Electrophoresis 2004; 25: 2526-2532.
46. Tannu NS, Rao VK, Chaudhary RM, Giorgianni F, Saeed AE, Gao Y et al. Comparative proteomes of the proliferating C(2)C(12) myoblasts and fully differentiated myotubes reveal the complexity of the skeletal muscle differentiation program. Mol Cell Proteomics 2004; 3: 1065-1082.
47. Steinberg TH, Agnew BJ, Gee KR, Leung WY, Goodman T, Schulenberg B et al. Global quantitative phosphoprotein analysis using multiplexed proteomics technology. Proteomics 2003; 3: 1128-1144.
48. Ullian EM, Christopherson KS, Barres BA. Role for glia in synaptogenesis. Glia 2004; 47: 209-216.
49. Narita M, Miyatake M, Shibasaki M, Shindo K, Nakamura A, Kuzumaki N et al. Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse. Neuropsychopharmacology 2006; 31: 2476-2488.
50. Bowers MS, Kalivas PW. Forebrain astroglial plasticity is induced following withdrawal from repeated cocaine administration. Eur J Neurosci 2003; 17: 1273-1278.
51. Beitner-Johnson D, Guitart X, Nestler EJ. Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J Neurochem 1993; 61: 1766-1773.
52. Haydon PG. Glia: listening and talking to the synapse. Nat Rev Neurosci 2001; 2: 185-193.
53. Weinstein DE, Shelanski ML, Liem RK. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 1991; 112: 1205-1213.
54. Fattore L, Puddu MC, Picciau S, Cappai A, Fratta W, Serra GP et al. Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy. Neuroscience 2002; 110: 1-6.
55. Porter JT, McCarthy KD. Astrocytic neurotransmitter receptors in situ and in vivo. Prog Neurobiol 1997; 51: 439-455.
56. Laping NJ, Teter B, Nichols NR, Rozovsky I, Finch CE. Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol 1994; 4: 259-275.
57. Fields RD, Stevens-Graham B. New insights into neuron-glia communication. Science 2002; 298: 556-562.
58. Ehlers MD, Fung ET, O'Brien RJ, Huganir RL. Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J Neurosci 1998; 18: 720-730.
59. Ratnam J, Teichberg VI. Neurofilament-light increases the cell surface expression of the N-methyl-D-aspartate receptor and prevents its ubiquitination. J Neurochem 2005; 92: 878-885.
60. Nakamura Y, Takeda M, Angelides KJ, Tanaka T, Tada K, Nishimura T. Effect of phosphorylation on 68KDa neurofilament subunit protein assembly by the cyclic AMP dependent protein kinase in vitro. Biochem Biophys Res Commun 1990; 169: 744-750.
61. Gill SR, Wong PC, Monteiro MJ, Cleveland DW. Assembly properties of dominant and recessive mutations in the small mouse neurofilament (NF-L) subunit. J Cell Biol 1990; 111: 2005-2019.
62. Sihag RK, Nixon RA. Identification of Ser-55 as a major protein kinase A phosphorylation site on the 70-kDa subunit of neuro-filaments. Early turnover during axonal transport. J Biol Chem 1991; 266: 18861-18867.
63. Nixon RA, Sihag RK. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci 1991; 14: 501-506.
64. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 2005; 233: 183-198.
65. Porrino LJ, Lyons D, Smith HR, Daunais JB, Nader MA. Cocaine self-administration produces a progressive involvement of limbic, association, and sensorimotor striatal domains. J Neurosci 2004; 24: 3554-3562.
66. Sarafian TA, Verity MA, Vinters HV, Shih CC, Shi L, Ji XD et al. Differential expression of peroxiredoxin subtypes in human brain cell types. J Neurosci Res 1999; 56: 206-212.
67. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005; 38: 1543-1552.
68. Yim MB, Chae HZ, Rhee SG, Chock PB, Stadtman ER. On the protective mechanism of the thiol-specific antioxidant enzyme against the oxidative damage of biomacromolecules. J Biol Chem 1994; 269: 1621-1626.
69. Kim H, Lee TH, Park ES, Suh JM, Park SJ, Chung HK et al. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 2000; 275: 18266-18270.
70. Kloss MW, Rosen GM, Rauckman EJ. Biotransformation of norcocaine to norcocaine nitroxide by rat brain microsomes. Psychopharmacology (Berl) 1984; 84: 221-224.
71. Dietrich JB, Mangeol A, Revel MO, Burgun C, Aunis D, Zwiller J. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology 2005; 48: 965-974.
72. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000; 463: 247-283.
73. Guindalini C, O'Gara C, Laranjeira R, Collier D, Castelo A, Vallada H et al. A GSTP1 functional variant associated with cocaine dependence in a Brazilian population. Pharmacogenet Genomics 2005; 15: 891-893.
74. Whiteheart SW, Griff IC, Brunner M, Clary DO, Mayer T, Buhrow SA et al. SNAP family of NSF attachment proteins includes a brain-specific isoform. Nature 1993; 362: 353-355.
75. Jahn R, Lang T, Sudhof TC. Membrane fusion. Cell 2003; 112: 519-533.
76. Schiavo G, Gmachl MJ, Stenbeck G, Sollner TH, Rothman JE. A possible docking and fusion particle for synaptic transmission. Nature 1995; 378: 733-736.
77. Hanley JG, Khatri L, Hanson PI, Ziff EB. NSF ATPase and alpha-/ beta-SNAPs disassemble the AMPA receptor-PICK1 complex. Neuron 2002; 34: 53-67.
78. Mansuy V, Boireau W, Fraichard A, Schlick JL, Jouvenot M, Delage-Mourroux R. GEC1, a protein related to GABARAP, interacts with tubulin and GABA(A) receptor. Biochem Biophys Res Commun 2004; 325: 639-648.
79. Wang H, Olsen RW. Binding of the GABA(A) receptor-associated protein (GABARAP) to microtubules and microfilaments suggests involvement of the cytoskeleton in GABARAPGABA(A) receptor interaction. J Neurochem 2000; 75: 644-655.
80. Stenmark H, Olkkonen VM. The Rab GTPase family. Genome Biol 2001; 2: REVIEWS3007.
81. Pfeffer SR, Dirac-Svejstrup AB, Soldati T. Rab GDP dissociation inhibitor: putting rab GTPases in the right place. J Biol Chem 1995; 270: 17057-17059.
82. Novick P, Zerial M. The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol 1997; 9: 496-504.
83. Takai Y, Sasaki T, Shirataki H, Nakanishi H. Rab3A small GTP-binding protein in Ca(2+)-dependent exocytosis. Genes Cells 1996; 1: 615-632. (Pubitemid 126673153)
84. Ishizaki H, Miyoshi J, Kamiya H, Togawa A, Tanaka M, Sasaki T et al. Role of rab GDP dissociation inhibitor alpha in regulating plasticity of hippocampal neurotransmission. Proc Natl Acad Sci USA 2000; 97: 11587-11592.